Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Dompé, Mesoblast, Mustang, Oblato, Pharmacyte.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: AB Science, Amgen, Asklepios, Binex, Biomx, Boehringer, Brickbio, City of Hope, Clene, Decode, Enosi, Evotec, Harbour, Highlight, Idorsia, Igyxos, Körber, Lyell, Magenta, Menlo, Merck, Oncimmune, Orca, Parnell, Pharmabcine, Preveceutical, Reveragen, Revive, Santhera, Selexis, Sorrento, Sunesis, Twist, Vyne, Walvax.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abivax, Aerpio, Algernon, Bicycle, Janssen, Nicox, Nocion, Poxel, Rocket, SAB, Tetra Bio-Pharma, Treadwell, X4.

Biopharmas raising money in public or private financings, including: Aditx, Evogene, Immunovant, Iterum, Sun.

New hires and promotions in the biopharma industry, including: Brainstorm Cell, Diffusion, Galectin, Genprex, Immunovia, LB, Magenta, Metacrine, Promethera, Rewind, Ultragenyx, Vir.

New hires and promotions in the biopharma industry in Asia-Pacific, including: Acepodia, Recce Pharmaceuticals, Sumitomo Dainippon.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: 3Sbio, Can-Fite, Capricor, Cstone, FSD, Gilead Sciences, Hifibio, Laurent, Revive, Sirtex Medical US, Sound, TLC, Xortx.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Akari, Astrazeneca, Glaxosmithkline, Mereo, Orpheris, Ovid, Redhill, Takeda, Union, Vir.

Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: Akers, Almirall, Altimmune, Ascentage, Astrazeneca, Beigene, Beximco, Bharat Biotech International, Bioage Labs, Biocryst, Biontech, Clinuvel, Elixiron Immunotherapeutics, Fosun Industrial, Heat Biologics, Hitgen, Immutep, Jacobson, Kalos, Mannin Research, Moderna, Novavax, Oncology Venture, Otsuka, Pluristem, Premas, Proteus Digital Health, PT Bio Farma, Q Biomed, Qualigen, Resverlogix, Serum Institute of India, Shanghai Fosun, Singlomics (Beijing Danxu), Sinovac, Starpharma Holdings, Takeda, Therapure, Tyme Technologies, University of Melbourne, Vaccitech, VBI Vaccines.

Biopharmas in Asia-Pacific raising money in public or private financings, including: Cocrystal, J-Pharma.